Agenix(澳大利亚)
Agenix
Agenix www.agenix.comAgenix创建于1982年,该公司是基于昆士兰理工学院成立的一个生物制药和研究集团,该公司的主要业务是研发单克隆抗体诊断程序。该公司拥有两个全资子公司,其中一个为AgenBiomedical,另一个为AgenixBiopharmaceutical,后者位于中国上海。AgenixlistedontheAustralianSecuritiesExchange
in1987.Today,Agenix’sleadproductcandidateisThromboView®,anovelradio-labelledmonoclonalantibodyimagingmodalityforpulmonaryembolism(PE)anddeepveinthrombosis(DVT).ThromboView®hassuccessfullycompletedtwoU.S. FDAPhaseIIclinicaltrialsandisinpartneringdiscussionsforPhaseIIItrials.Agenix’shumanhealthdiagnosticsplatform,DiagnostIQ®isapatenteddisposablepoint-ofcaretestdevicewithreader.DiagnostIQ®utilisesanantibody/antigenprintedmembrane,auniquepre-filterdeviceandanincubationchamberinaflow-throughformattocreateasensitiveandquantitative,rapid,test.Thepatentedtechnologyprovidesthepotential